KY SB139 | 2015 | Regular Session

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on February 10 2015 - 25% progression, died in committee
Action: 2015-02-12 - to Health & Welfare (S)
Pending: Senate Health and Welfare Committee
Text: Latest bill text (Draft #1) [MS Word]

Summary

Create new sections of KRS Chapter 217 to define terms; permit eligible patients to use investigational drugs, biological products, or devices for a terminal illness; establish the conditions for use of such experimental treatments; prohibit sanctions of health care providers; clarify the duties of health care insurers regarding experimental treatments; prohibit certain actions by state officials; provide immunity for use and recommendation of experimental treatments.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

AN ACT relating to use of experimental treatments for terminal illnesses.

Sponsors


History

DateChamberAction
2015-02-12Senateto Health & Welfare (S)
2015-02-10Senateintroduced in Senate

Kentucky State Sources


Bill Comments

feedback